Zinc-promoted reduction of 13-oxobaccatin III derivatives leads to 11,
12-dihydro analogs. The reduced products are unstable and a skeleton r
earrangement occurs leading to the cleavage of the C-10, C-11 bond. Th
e 11,12-dihydrobaccatin III derivatives do not retain antitubulin acti
vity.